Medical AI Re-Acquires A Grades from Both Korea Exchange Tech Evaluators

Medical AI announced it has re-acquired A grades from both specialized technology evaluation agencies designated by the Korea Exchange for its Deep Tech technology special listing. The company had previously received A grades from the same two agencies in February 2025, according to venturesquare.net.

The company's diagnostic support system is built on a foundation model trained on approximately 20 million ECG data points, used to support the diagnosis of heart conditions.

Medical AI holds 555 related patents, of which 106 are registered.

Its AiTiA Series products have obtained regulatory approvals in Europe, the UK, India, Singapore, Kenya, Vietnam, Indonesia and Thailand. AiTiALVSD has been used in more than 239 medical institutions worldwide, with cumulative paid prescriptions surpassing 2.9 million.

Earlier recognition

In October 2024, Medical AI received confirmation of a national strategic technology from the Ministry of Science and ICT and KISTEP for its ECG analysis AI algorithm-based heart disease diagnosis technology. In March 2025, the company was selected as an inaugural winner of the American College of Cardiology's Global Digital Health Award.